
Primary Antibodies
Primary antibodies are immunoglobulins that recognize and bind to a specific antigen of interest with high affinity and specificity to purify, detect, and measure that antigen. Includes antibody pairs for specific biochemical applications.

All Primary Antibodies
(131,846)

Primary Antibody Matched Pairs
(33)

Protein Interaction Antibody Pairs
(5)

Protein Phosphorylation Antibody Pairs
(1)

1
–
15
of
123,319
results
Invitrogenâ„¢ Myogenin Recombinant Rabbit Monoclonal Antibody (JE60-39)
Rabbit Recombinant Monoclonal Antibody
Content And Storage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
---|---|
Target Species | Human,Mouse,Rat |
Host Species | Rabbit |
Conjugate | Unconjugated |
Applications | Western Blot,Immunocytochemistry |
Form | Liquid |
Gene Accession No. | P12979, P15173, P20428 |
Isotype | IgG |
Concentration | 1 mg/mL |
Antigen | Myogenin |
Gene Symbols | MYOG |
Regulatory Status | RUO |
Purification Method | Protein A |
Gene Alias | bHLHc3; Class C basic helix-loop-helix protein 3; MYF4; Myf-4; myo; MYOD1-related protein; MYOG; Myogenic factor 4; Myogenic factor-4; myogenin; myogenin (myogenic factor 4) |
Gene | MYOG |
Product Type | Antibody |
Gene ID (Entrez) | 17928, 29148, 4656 |
Formulation | TBS with 0.05% BSA, 40% glycerol and 0.05% sodium azide; pH 7.4 |
Immunogen | Synthetic peptide within human myogenin aa 1-50/224. |
Classification | Recombinant Monoclonal |
Primary or Secondary | Primary |
Clone | JE60-39 |
Content And Storage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
---|---|
Target Species | Virus |
Host Species | Rabbit |
Conjugate | Unconjugated |
Applications | Immunohistochemistry,Western Blot,Immunocytochemistry |
Form | Liquid |
Isotype | IgG |
Concentration | 1.0 mg/mL |
Antigen | SARS Coronavirus Spike Protein |
Regulatory Status | RUO |
Purification Method | Antigen affinity chromatography |
Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
Product Type | Antibody |
Formulation | PBS with 0.02% sodium azide |
Immunogen | Synthetic peptide corresponding to residues 1124-1140 of the putative SARS Spike glycoprotein. |
Classification | Polyclonal |
Primary or Secondary | Primary |
CD20 Monoclonal Antibody (2H7), Brilliant Ultra Violetâ„¢ 395, eBioscienceâ„¢, Invitrogenâ„¢
Mouse Monoclonal Antibody
Content And Storage | 4°C, store in dark, DO NOT FREEZE! |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Brilliant Ultraviolet 395 |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG2b κ |
Gene Accession No. | P11836 |
Concentration | 5 μL/Test |
Antigen | CD20 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | AA960661; APY; ATOPY; B1; B-cell differentiation antigen Ly-44; B-lymphocyte antigen CD20; B-lymphocyte cell-surface antigen B1; B-lymphocyte surface antigen B1; Bp35; Cd20; CD20 antigen; CD20 cell surface protein; CD20 receptor; CVID5; EGK_06167; Fc epsilon receptor I beta chain; Fc Fragment of IgE high affinity I receptor for beta polypeptide; FCER1B; High affinity immunoglobulin epsilon receptor subunit beta; IgE Fc receptor subunit beta; IGEL; IGER; IGHER; LEU16; LEU-16; Leukocyte surface antigen Leu-16; Ly44; Ly-44; Lymphocyte antigen 44; membrane spanning 4-domains A1; membrane-spanning 4-domains subfamily A member 1; membrane-spanning 4-domains, subfamily A, member 1; membrane-spanning 4-domains, subfamily A, member 2; MGC3969; MS4A1; MS4A2; S7 |
Gene | Ms4a1 |
Product Type | Antibody |
Gene ID (Entrez) | 931 |
Formulation | PBS with BSA and 0.09% sodium azide; pH 7.2 |
Classification | Monoclonal |
Primary or Secondary | Primary |
Clone | 2H7 |
CD20 Monoclonal Antibody (2H7), Brilliant Ultra Violetâ„¢ 805, eBioscienceâ„¢, Invitrogenâ„¢
Mouse Monoclonal Antibody
Content And Storage | 4°C, store in dark, DO NOT FREEZE! |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Brilliant Ultraviolet 805 |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG2b κ |
Gene Accession No. | P11836 |
Concentration | 5 μL/Test |
Antigen | CD20 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | AA960661; APY; ATOPY; B1; B-cell differentiation antigen Ly-44; B-lymphocyte antigen CD20; B-lymphocyte cell-surface antigen B1; B-lymphocyte surface antigen B1; Bp35; Cd20; CD20 antigen; CD20 cell surface protein; CD20 receptor; CVID5; EGK_06167; Fc epsilon receptor I beta chain; Fc Fragment of IgE high affinity I receptor for beta polypeptide; FCER1B; High affinity immunoglobulin epsilon receptor subunit beta; IgE Fc receptor subunit beta; IGEL; IGER; IGHER; LEU16; LEU-16; Leukocyte surface antigen Leu-16; Ly44; Ly-44; Lymphocyte antigen 44; membrane spanning 4-domains A1; membrane-spanning 4-domains subfamily A member 1; membrane-spanning 4-domains, subfamily A, member 1; membrane-spanning 4-domains, subfamily A, member 2; MGC3969; MS4A1; MS4A2; S7 |
Gene | Ms4a1 |
Product Type | Antibody |
Gene ID (Entrez) | 931 |
Formulation | PBS with BSA and 0.09% sodium azide; pH 7.2 |
Classification | Monoclonal |
Primary or Secondary | Primary |
Clone | 2H7 |
F4/80 Monoclonal Antibody (BM8), Brilliant Ultra Violetâ„¢ 805, eBioscienceâ„¢, Invitrogenâ„¢
Rat Monoclonal Antibody
Content And Storage | 4°C, store in dark, DO NOT FREEZE! |
---|---|
Target Species | Mouse |
Host Species | Rat |
Conjugate | Brilliant Ultraviolet 805 |
Applications | Flow Cytometry |
Form | Liquid |
Isotype | IgG2a κ |
Gene Accession No. | Q61549 |
Concentration | 0.2 mg/mL |
Antigen | F4/80 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | ADGRE1; Adhesion G protein-coupled receptor E1; Adhesion G protein-coupled receptor E2; cell surface glycoprotein EMR1; cell surface glycoprotein F4/80; DD7A5-7; EGF-like module containing, mucin-like, hormone receptor-like 1; EGF-like module containing, mucin-like, hormone receptor-like sequence 1; EGF-like module receptor 1; EGF-like module-containing mucin-like hormone receptor-like 1; EGF-TM7; Emr1; EMR1 hormone receptor; F4/80; Gpf480; Ly71; lymphocyte antigen 71; TM7LN3 |
Gene | ADGRE1 |
Product Type | Antibody |
Gene ID (Entrez) | 13733 |
Formulation | PBS with BSA and 0.09% sodium azide; pH 7.2 |
Classification | Monoclonal |
Primary or Secondary | Primary |
Clone | BM8 |
Content And Storage | 4°C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor 700 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P34810 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD68 |
Gene Symbols | Cd68 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | CD68; CD68 antigen; CD68 molecule; GP110; Lamp4; macrophage antigen CD68; macrosialin; Scard1; scavenger receptor class D, member 1; similar to CD68 antigen |
Gene | Cd68 |
Product Type | Antibody |
Gene ID (Entrez) | 968 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Classification | Monoclonal |
Primary or Secondary | Primary |
Clone | KP1 |
Content And Storage | 4°C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 555 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P02533, P02538, P04264, P05783, P05787, P08727, P08729, P08779, P12035, P13645, P13646, P13647, P19012, P19013, P35908, Q01546, Q04695, Q7Z794 |
Isotype | IgG1 |
Concentration | 0.2 mg/mL |
Antigen | Cytokeratin Pan Type I/II |
Gene Symbols | KRT1, KRT10, KRT13, KRT14, KRT15, KRT16, KRT17, KRT18, KRT19, KRT2, KRT3, KRT4, KRT5, Krt6a, KRT7, KRT76, KRT77, KRT8 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | 2310016L08Rik; 3300001P10Rik; 39.1; 40-kDa keratin intermediate filament; 47 kDa cytokeratin; 56 kDa cytokeratin; 57kd keratin; 57kDa keratin; 58 kDa cytokeratin; 60-kDa keratin; 63kDa Keratin; 65 kDa cytokeratin; 67 kDa cytokeratin; AA960620; adult keratin; AI324768; AI528832; AI626930; AI663979; AL022697; alpha keratin; AU019895; AW108092; AW146334; basic epidermal type II cytokeratin (carboxy-terminal region, clone pUF164); BB005427; BCIE; BIE; Card2; cell proliferation-inducing gene 46 protein; CK 2e; CK1; CK-1; CK10; CK-10; CK13; CK-13; CK14; CK-14; CK15; CK-15; CK16; CK-16; CK-17; CK18; CK-18; CK19; CK-19; CK-1B; CK-2e; CK3; CK-3; CK4; CK-4; CK5; CK-5; ck55; CK6A; CK-6A; CK6C; CK-6C; CK6D; CK-6D; CK-6E; CK7; CK-7; CK8; CK-8; CYK18; CYK4; CYK8; CYKER; cytokeratin 1; cytokeratin 10; cytokeratin 13; cytokeratin 14; cytokeratin 15; cytokeratin 16; cytokeratin 18; cytokeratin 19; cytokeratin 3; cytokeratin 4; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin 7; cytokeratin 8; cytokeratin 8 (370 AA); cytokeratin endo A; Cytokeratin endo B; cytokeratin otokeratin; cytokeratin type II; cytokeratin type II, component Ib/c; cytokeratin type II, component III; cytokeratin VIB; cytokeratin VII; cytokeratin-1; Cytokeratin-10; cytokeratin-13; Cytokeratin-14; cytokeratin-15; Cytokeratin-16; cytokeratin-17; Cytokeratin-18; cytokeratin-19; Cytokeratin-1B; Cytokeratin-2e; cytokeratin-3; Cytokeratin-4; cytokeratin-5; Cytokeratin-6A; cytokeratin-6B; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; cytokeratin-7; Cytokeratin-8; cytokeratin-A; Cytoskeletal 57 kDa keratin; D130054E02Rik; D15Wsu77e; DDD; DDD1; ear specific cytokeratin; EBS2; ebs3; ebs4; EGK_03684; EGK_03685; EHK; EHK1; Endo B; EndoA; EndoC; epidermal keratin 10; epidermal keratin VII; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; epidermolysis bullosa simplex, Dowling-Meara, Koebner; epidermolytic hyperkeratosis 1; epidermolytic hyperkeratosis; keratosis palmaris et plantaris; epithelial keratin 1; epithelial keratin 10; epithelial keratin 2e; Epithelial keratin-1; Epithelial keratin-2e; EPPK; fgk; fin and gill keratin; FNEPPK; focal non-epidermolytic palmoplantar keratoderma; GK-19; Hair alpha protein; HMWCK; Hom s 5; I79_019823; I79_021074; I79_023185; I79_024335; intermediate filament protein; K1; K10; K13; K14; K15; K16; K17; K18; K19; K1B; K1C1; K1CO; K1CP; K1CS; K2C7; K2C8; K2e; K3; K3 keratin; K4; K5; K6A; K6a keratin; K6C; K6D; K7; K77; K8; Ka10; Ka13; Ka14; Ka15; Ka16; Ka17; Ka19; kamp-keratin derived antimicrobial peptide; Kb1; Kb2; Kb4; Kb7; KDAMP; KER1; Ker10; Ker2; KERA; keratin; keratin 1; keratin 1 (epidermolytic hyperkeratosis); keratin 1, type II; keratin 10; keratin 10 (epidermolytic hyperkeratosis); keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris); keratin 10, type I; keratin 10, type I L homeolog; keratin 10, type I S homeolog; keratin 12, gene 2 S homeolog; keratin 13; keratin 13, type I; keratin 13, type I S homeolog; keratin 14; keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner); keratin 14, type I; keratin 14, type I L homeolog; keratin 15; keratin 15, gene 1 S homeolog; keratin 15, type I; keratin 16; keratin 16 (focal non-epidermolytic palmoplantar keratoderma); keratin 16, type I; keratin 16, type I S homeolog; keratin 17; keratin 17 L homeolog; keratin 17, type I; keratin 17, type I L homeolog; keratin 18; keratin 18, type I; keratin 19; keratin 19 S homeolog; keratin 19 S homeolog; keratin 19; keratin 19, type I; Keratin 1B; keratin 2; keratin 2 (epidermal ichthyosis bullosa of Siemens); keratin 2 epidermis; keratin 2, type II; keratin 24; keratin 2A; keratin 2A (epidermal ichthyosis bullosa of Siemens); keratin 3; keratin 3, type II; keratin 4; keratin 4, type II; keratin 5; keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) |
Gene | KRT16 |
Product Type | Antibody |
Gene ID (Entrez) | 374454, 3848, 3849, 3850, 3851, 3852, 3853, 3855, 3856, 3858, 3860, 3861, 3866, 3868, 3872, 3875, 3880, 51350 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Immunogen | Human epidermal keratin. |
Classification | Cocktail |
Primary or Secondary | Primary |
Clone | AE1/AE3 |
Invitrogenâ„¢ CD8 alpha Monoclonal Antibody (C8/144B), Alexa Fluorâ„¢ Plus 594
Mouse Monoclonal Antibody
Content And Storage | 4°C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 594 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P01732, P10966 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD8 alpha |
Gene Symbols | Cd8a, CD8B |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | BB154331; CD8; CD8 alpha; CD8 alpha chain; CD8 alpha chain precursor; CD8 antigen; CD8 antigen 32 kDa chain; CD8 antigen 37 kDa chain; CD8 antigen alpha polypeptide; CD8 antigen alpha protein; CD8 antigen alpha protein precursor; CD8 antigen alpha-chain; CD8 antigen beta polypeptide; CD8 antigen beta polypeptide precursor; CD8 antigen beta-chain; CD8 antigen, alpha chain; CD8 antigen, alpha polypeptide; CD8 antigen, alpha polypeptide (p32); CD8 antigen, alpha-chain; CD8 antigen, beta chain; CD8 antigen, beta chain 1; CD8 antigen, beta polypeptide; CD8 antigen, beta polypeptide 1 (p37); CD8 antigen, beta-chain; CD8 beta; CD8 beta chain; CD8 beta-2; CD8a; CD8A antigen alpha; CD8a molecule; CD8A; T-cell surface glycoprotein; CD8alpha; CD8B; CD8b antigen; CD8b molecule; CD8b molecule pseudogene; Cd8b1; CD8beta; CD8BP; fCD8; LEU2; Leu-2; Leu2 T-lymphocyte antigen; leu-2a; Ly-2; LY3; Ly-3; Ly-35; Ly-B; Ly-C; Lymphocyte antigen 3; Lyt2; Lyt-2; Lyt-2.1 lymphocyte differentiation antigen (AA at 100); Lyt3; Lyt-3; MAL; membrane glycoprotein; membrane protein; OKT8 T-cell antigen; OX-8 membrane antigen; p32; P37; RHACD8-4; T cell co-receptor; T lymphocyte surface glycoprotein beta chain; T8 T-cell antigen; T-cell antigen Leu2; T-cell membrane glycoprotein Ly-3; T-cell surface glycoprotein; T-cell surface glycoprotein CD8 alpha chain; T-cell surface glycoprotein CD8 beta chain; T-cell surface glycoprotein Lyt-2; T-cell surface glycoprotein Lyt-3; T-cell surface molecule; T-lymphocyte differentiation antigen T8/Leu-2; type I transmembrane glycoprotein |
Gene | CD8B |
Product Type | Antibody |
Gene ID (Entrez) | 925, 926 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Immunogen | A 13 amino acid synthetic peptide from the C-terminal cytoplasmic domain of alpha chain of human CD8 molecule. |
Classification | Monoclonal |
Primary or Secondary | Primary |
Clone | C8/144B |
Content And Storage | 4°C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 594 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P02533, P02538, P04264, P05783, P05787, P08727, P08729, P08779, P12035, P13645, P13646, P13647, P19012, P19013, P35908, Q01546, Q04695, Q7Z794 |
Isotype | IgG1 |
Concentration | 0.2 mg/mL |
Antigen | Cytokeratin Pan Type I/II |
Gene Symbols | KRT1, KRT10, KRT13, KRT14, KRT15, KRT16, KRT17, KRT18, KRT19, KRT2, KRT3, KRT4, KRT5, Krt6a, KRT7, KRT76, KRT77, KRT8 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | 2310016L08Rik; 3300001P10Rik; 39.1; 40-kDa keratin intermediate filament; 47 kDa cytokeratin; 56 kDa cytokeratin; 57kd keratin; 57kDa keratin; 58 kDa cytokeratin; 60-kDa keratin; 63kDa Keratin; 65 kDa cytokeratin; 67 kDa cytokeratin; AA960620; adult keratin; AI324768; AI528832; AI626930; AI663979; AL022697; alpha keratin; AU019895; AW108092; AW146334; basic epidermal type II cytokeratin (carboxy-terminal region, clone pUF164); BB005427; BCIE; BIE; Card2; cell proliferation-inducing gene 46 protein; CK 2e; CK1; CK-1; CK10; CK-10; CK13; CK-13; CK14; CK-14; CK15; CK-15; CK16; CK-16; CK-17; CK18; CK-18; CK19; CK-19; CK-1B; CK-2e; CK3; CK-3; CK4; CK-4; CK5; CK-5; ck55; CK6A; CK-6A; CK6C; CK-6C; CK6D; CK-6D; CK-6E; CK7; CK-7; CK8; CK-8; CYK18; CYK4; CYK8; CYKER; cytokeratin 1; cytokeratin 10; cytokeratin 13; cytokeratin 14; cytokeratin 15; cytokeratin 16; cytokeratin 18; cytokeratin 19; cytokeratin 3; cytokeratin 4; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin 7; cytokeratin 8; cytokeratin 8 (370 AA); cytokeratin endo A; Cytokeratin endo B; cytokeratin otokeratin; cytokeratin type II; cytokeratin type II, component Ib/c; cytokeratin type II, component III; cytokeratin VIB; cytokeratin VII; cytokeratin-1; Cytokeratin-10; cytokeratin-13; Cytokeratin-14; cytokeratin-15; Cytokeratin-16; cytokeratin-17; Cytokeratin-18; cytokeratin-19; Cytokeratin-1B; Cytokeratin-2e; cytokeratin-3; Cytokeratin-4; cytokeratin-5; Cytokeratin-6A; cytokeratin-6B; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; cytokeratin-7; Cytokeratin-8; cytokeratin-A; Cytoskeletal 57 kDa keratin; D130054E02Rik; D15Wsu77e; DDD; DDD1; ear specific cytokeratin; EBS2; ebs3; ebs4; EGK_03684; EGK_03685; EHK; EHK1; Endo B; EndoA; EndoC; epidermal keratin 10; epidermal keratin VII; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; epidermolysis bullosa simplex, Dowling-Meara, Koebner; epidermolytic hyperkeratosis 1; epidermolytic hyperkeratosis; keratosis palmaris et plantaris; epithelial keratin 1; epithelial keratin 10; epithelial keratin 2e; Epithelial keratin-1; Epithelial keratin-2e; EPPK; fgk; fin and gill keratin; FNEPPK; focal non-epidermolytic palmoplantar keratoderma; GK-19; Hair alpha protein; HMWCK; Hom s 5; I79_019823; I79_021074; I79_023185; I79_024335; intermediate filament protein; K1; K10; K13; K14; K15; K16; K17; K18; K19; K1B; K1C1; K1CO; K1CP; K1CS; K2C7; K2C8; K2e; K3; K3 keratin; K4; K5; K6A; K6a keratin; K6C; K6D; K7; K77; K8; Ka10; Ka13; Ka14; Ka15; Ka16; Ka17; Ka19; kamp-keratin derived antimicrobial peptide; Kb1; Kb2; Kb4; Kb7; KDAMP; KER1; Ker10; Ker2; KERA; keratin; keratin 1; keratin 1 (epidermolytic hyperkeratosis); keratin 1, type II; keratin 10; keratin 10 (epidermolytic hyperkeratosis); keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris); keratin 10, type I; keratin 10, type I L homeolog; keratin 10, type I S homeolog; keratin 12, gene 2 S homeolog; keratin 13; keratin 13, type I; keratin 13, type I S homeolog; keratin 14; keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner); keratin 14, type I; keratin 14, type I L homeolog; keratin 15; keratin 15, gene 1 S homeolog; keratin 15, type I; keratin 16; keratin 16 (focal non-epidermolytic palmoplantar keratoderma); keratin 16, type I; keratin 16, type I S homeolog; keratin 17; keratin 17 L homeolog; keratin 17, type I; keratin 17, type I L homeolog; keratin 18; keratin 18, type I; keratin 19; keratin 19 S homeolog; keratin 19 S homeolog; keratin 19; keratin 19, type I; Keratin 1B; keratin 2; keratin 2 (epidermal ichthyosis bullosa of Siemens); keratin 2 epidermis; keratin 2, type II; keratin 24; keratin 2A; keratin 2A (epidermal ichthyosis bullosa of Siemens); keratin 3; keratin 3, type II; keratin 4; keratin 4, type II; keratin 5; keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) |
Gene | KRT16 |
Product Type | Antibody |
Gene ID (Entrez) | 374454, 3848, 3849, 3850, 3851, 3852, 3853, 3855, 3856, 3858, 3860, 3861, 3866, 3868, 3872, 3875, 3880, 51350 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Immunogen | Human epidermal keratin. |
Classification | Cocktail |
Primary or Secondary | Primary |
Clone | AE1/AE3 |
Content And Storage | 4°C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 647 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P01730 |
Isotype | IgG2b κ |
Concentration | 0.2 mg/mL |
Antigen | CD4 |
Gene Symbols | CD4 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | Activation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD4; CD4 antigen; CD4 antigen (p55); CD4 antigen p55; Cd4 molecule; CD4 precursor; CD4 receptor; CD4, allele 1; cd4a; CD4mut; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 molecule; cell surface glycoprotein CD4; costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; fCD4; L3T4; LAB7; Leu-3; Ly-4; lymphocyte antigen CD4; lymphocyte antigen CD4 precursor; membrane protein; p55; T-cell differentiation antigen L3T4; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4; T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (T-cell differentiation antigen L3T4); T-lymphocyte activation antigen CD80; W3/25; W3/25 antigen |
Gene | CD4 |
Product Type | Antibody |
Gene ID (Entrez) | 920 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Classification | Monoclonal |
Primary or Secondary | Primary |
Clone | N1UG0 |
Ki-67 Monoclonal Antibody (SolA15), Alexa Fluorâ„¢ Plus 555
Ki-67 Monoclonal Antibody (SolA15), Alexa Fluorâ„¢ Plus 555
Invitrogenâ„¢ CD11b Monoclonal Antibody (C67F154), Alexa Fluorâ„¢ Plus 594
Mouse Monoclonal Antibody
Content And Storage | 4°C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 594 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P11215 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD11b |
Gene Symbols | ITGAM |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | antigen CD11b (p170); antigen CD11b (p170); macrophage antigen alpha polypeptide; CD11 antigen-like family member B; CD11b; CD11B (p170); CD11b/CD18; cell surface glycoprotein MAC-1 alpha subunit; cell surface glycoprotein MAC-1 subunit alpha; complement component 3 receptor 3 subunit; complement component receptor 3 alpha-a; complement receptor type 3; CR3; CR-3 alpha chain; CR3A; F730045J24Rik; integrin alpha M; integrin alpha-M; integrin subunit alpha M; integrin, alpha M; integrin, alpha M (complement component 3 receptor 3 subunit); ITGAM; Leukocyte adhesion receptor MO1; leukocyte integrin alpha-M chain; LOC100351865; Ly-40; MAC1; Mac-1; Mac-1 alpha; Mac-1 alpha (Mac1A); MAC-1 alpha subunit; MAC1A; Mac-1a; macrophage antigen alpha; macrophage antigen alpha polypeptide; MGC117044; MO1A; Neutrophil adherence receptor; neutrophil adherence receptor alpha-M subunit; SLEB6; unnamed protein product |
Gene | ITGAM |
Product Type | Antibody |
Gene ID (Entrez) | 3684 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Immunogen | E. coli fragment of part of extracellular domain (aa 250-350). |
Classification | Monoclonal |
Primary or Secondary | Primary |
Clone | C67F154 |
Content And Storage | 4°C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor 420 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P08670 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | Vimentin |
Gene Symbols | Vim |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | cb28; class-III intermediate microfilament; CTRCT30; epididymis luminal protein 113; FLJ36605; HEL113; intermediate filament; intermediate filament protein; RP11-124N14.1; similar to vimentin; VIM; VIME; Vimentin; vimentin C-terminus |
Gene | Vim |
Product Type | Antibody |
Gene ID (Entrez) | 7431 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Classification | Monoclonal |
Primary or Secondary | Primary |
Clone | V9 |